International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
International
Switzerland (French)
Business Development
Medien
Treffen Sie uns
Karriere
Kontakt
Unsere Produkte
Partner & Marken
Referenzen
Über Ewopharma
Vision/Mission
Unsere Werte
Unsere Strategie
Führung
Unternehmensverantwortung
Gebiet
Business Development
Medien
Treffen Sie uns
Karriere
Kontakt
International
Albania
Bosnia and Herzegovina
Bulgaria
Croatia
Czech Republic
Estonia
Hungary
Latvia
Lithuania
Kosovo
North Macedonia
Poland
Romania
Serbia
Slovakia
Slovenia
Switzerland (German)
International
Switzerland (French)
Medien
PRESSEMITTEILUNGEN
1
2
3
4
Nächste
31.07.2024
European Commission Approves Sugemalimab
Mehr lesen
03.06.2024
Allergycare AG becomes part of Ewopharma Group
Mehr lesen
27.05.2024
Ewopharma and CStone enter into a Strategic Partnership for Sugemalimab in Central Eastern Europe and Switzerland
Mehr lesen
30.01.2024
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Mehr lesen
31.05.2023
Neomed s.r.o. becomes part of Ewopharma Group
Mehr lesen
1
2
3
4
Nächste
![[Translate to Switzerland (German):]](/fileadmin/user_upload/Licensing_450606453.jpg "[Translate to Switzerland (German):]")
